Clinical Trials on Cognitive Ability General in Australia

Total 8111 results

CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
University of Adelaide
University of South Australia

Unknown

Ibudilast in the Treatment of Medication Overuse Headache

Medication Overuse Headache

Australia
Telix International Pty Ltd

Completed

131I-IPA and Concurrent XRT in Recurrent GBM (IPAX-1)

Glioblastoma Multiforme

Austria, Australia, Netherlands
Royal Adelaide Hospital

Completed

A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases

Neoplasm Metastasis | Brain Neoplasm

Australia
Donald Mabbott

Recruiting

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour (Met Med Can)

Cognitive Impairment | Medulloblastoma, Childhood

Canada, Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

Meningitis, Meningococcal

Australia
Daré Bioscience, Inc.

Completed

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA (DARE-VVA1)

Vulvar Atrophy

Australia
Women's and Children's Hospital, Australia
Allergan Australia Pty Ltd

Unknown

Exploring Hypertonia in Children With Cerebral Palsy (HypE-CP)

Cerebral Palsy.

Australia
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 XG005-03 Topical Study

Pain

Australia
The University of Western Australia

Completed

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Parkinson's Disease | Tremor

Australia
Daré Bioscience, Inc.

Completed

Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (DARE-HRT1)

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
Atridia Pty Ltd.

Completed

A Trial of HRS4800 Tables in Healthy Male Subjects

Pain

Australia
Xgene Pharmaceutical Pty Ltd

Completed

Pharmacokinetics Study of XG005 Capsule

Pain

Australia
iX Biopharma Ltd.

Completed

Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.

Pain

Australia
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 Pharmacokinetics, Safety, and Tolerability Study

Pain

Australia
iX Biopharma Ltd.

Completed

Study of Ketamine Administered Intravenously and by Sublingual Wafer

Pain

Australia
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group

Completed

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Primary Central Nervous System Lymphoma

Australia, New Zealand
The University of Western Australia
Royal Perth Hospital; Fiona Stanley Hospital; Perth Urology Clinic

Completed

Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury

Spinal Cord Injuries

Australia
Flinders University

Completed

Breathlessness Exertion and Morphine Sulphate (BEAMS)

Chronic Obstructive Pulmonary Disease | Dyspnea

Australia, New Zealand
Sir Charles Gairdner Hospital

Completed

Catheter Over Needle vs Catheter Through Needle

Nerve Block | Catheterization

Australia
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Recruiting

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Bacterial Infections

Australia
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

Bacterial Infections

Australia
University of Adelaide
Royal Adelaide Hospital

Not yet recruiting

The ARRC III Trial of Advanced Recovery Room Care (ARRC). A Pilot Registry at RAH (ARRCIII)

Economic Problems | Post-Surgical Complication

Australia
Zeria Pharmaceutical

Completed

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Dyspepsia

Australia
Institut Franco Europeen de Chiropratique

Unknown

the Hypoalgesic Effect of Spinal Manual Therapy

Back Pain

Australia
Sanofi

Completed

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Japanese Encephalitis

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Bacterial Infections | Healthy Volunteers

Australia
University of Adelaide
University of Southampton; Central Adelaide Local Health Network Incorporated

Terminated

Advanced Recovery Room Care II - Improved Recovery After Surgery (ARRCII)

Postoperative Complications | Cost-Benefit Analysis

Australia
GlaxoSmithKline

Terminated

A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study (Relative Bio)

Community-acquired Infection

Australia
Telethon Kids Institute

Recruiting

A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children (POPSICLE)

Chronic Pain

Australia
University of Adelaide
University of Sydney; Salk Institute for Biological Studies

Recruiting

Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes (OMIT)

Obesity

Australia
Viking Therapeutics, Inc.

Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Weight Loss | NASH

Australia
GlaxoSmithKline

Completed

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

Infections, Bacterial

Australia
South Australian Health and Medical Research Institute
University of Sydney; Telethon Kids Institute; Flinders University; Royal Adelaide... and other collaborators

Recruiting

Antibiotics and Vaccine Immune Responses Study (AVIRS)

Vaccine Response Impaired

Australia
Meiji Seika Pharma Co., Ltd.

Completed

A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595

Bacterial Infections | Healthy Volunteers

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
Seqirus

Completed

Study of a Pandemic Influenza Vaccine in Elderly Participants

Influenza

Australia
Lateral Pharma Pty Ltd
Southern Star Research Pty Ltd.

Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Radiculopathy Lumbar

Australia
Global Health Drug Discovery Institute
CMAX Clinical Research Pty Limited; Avance Clinical

Completed

SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects

COVID-19

Australia
Clover Biopharmaceuticals AUS Pty Ltd

Recruiting

First-in-human Safety and Immunogenicity Study of SCB-1019 in Healthy Adults

Respiratory Syncytial Virus Infection

Australia
GlaxoSmithKline

Terminated

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Infections, Bacterial

Australia
University of Adelaide
Commonwealth Scientific and Industrial Research Organisation, Australia; Isagenix... and other collaborators

Completed

AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)

Obesity

Australia
The University of Western Australia
Sir Charles Gairdner Hospital; Perron Institute for Neurological and Translational...

Withdrawn

Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome

Tourette's Syndrome

Australia
De Motu Cordis
Novotech (Australia) Pty Limited

Not yet recruiting

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Anaphylactic Reaction

Australia
The University of Western Australia
Osteology Foundation

Completed

Surgical Treatment of Peri-implantitis (STP)

Peri-Implantitis

Australia
Xalud Therapeutics, Inc.

Completed

Follow on Extension of XT-150-1-0201

Osteoarthritis, Knee

Australia
Boehringer Ingelheim

Completed

A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

Pulmonary Disease, Chronic Obstructive

Australia, New Zealand, United Kingdom
Zafgen, Inc.

Completed

An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

Obesity

Australia
Gmax Biopharm Australia Pty Ltd.

Completed

Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106

Overweight and Obesity

Australia

Clinical Trials on Cognitive Ability General in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations